Pouya Tahsili-Fahadan: New Machine Learning Model Enhances Risk Prediction in Acute Ischemic Stroke
Pouya Tahsili-Fahadan, Medical Director of Stroke at Inova Fairfax Hospital, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Translational Stroke Research, adding:
”I’m pleased to share our latest publication in Translational Stroke Research.
In this study, we developed and validated machine learning models that integrate automated quantitative cerebrovascular morphology, collateral assessment, and conventional clinical and imaging variables to improve prediction of major complications following endovascular thrombectomy in acute ischemic stroke.
This work represents a multidisciplinary collaboration between the Inova Fairfax Hospital (Inova Neuroscience and Spine Institute) and the University of California, Riverside.
Congratulations and sincere thanks to all of my co-authors and collaborators for their outstanding work.”
Title: Quantitative Cerebrovascular Analysis for Improved Prediction of Post-Stroke Complications
Authors: Aditi Deshpande, Jing Wang, Laith R. Altaweel, Seajin Yi, Zelalem Bahiru, Tahddeus J. Leiphart, Pouya Tahsili-Fahadan, Kaveh Laksari

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients